Norges Bank’s Alexion Pharmaceuticals ALXN Stock Holding History

Norges Bank’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,951,561	Closed	-$359M	–	2388
2021 Q2	$359M	Sell	1,951,561 -271,531	-12%	-$46.6M	0.08%	248
2021 Q1	$340M	Sell	2,223,092 -942,448	-30%	-$146M	0.08%	239
2020 Q4	$495M	Sell	3,165,540 -345,616	-10%	-$44.4M	0.12%	168
2020 Q3	$402M	Sell	3,511,156 -57,898	-2%	-$6.25M	0.11%	169
2020 Q2	$401M	Buy	3,569,054 +351,281	+11%	+$37.3M	0.12%	165
2020 Q1	$289M	Buy	3,217,773 +77,000	+2%	+$7.56M	0.1%	186
2019 Q4	$340M	Buy	3,140,773 +170,386	+6%	+$18.2M	0.09%	202
2019 Q3	$291M	Sell	2,970,387 -52,282	-2%	-$5.89M	0.09%	213
2019 Q2	$396M	Buy	3,022,669 +145,493	+5%	+$18.8M	0.12%	168
2019 Q1	$389M	Sell	2,877,176 -1,117,620	-28%	-$139M	0.13%	159
2018 Q4	$389M	Buy	3,994,796 +344,583	+9%	+$40.7M	0.14%	134
2018 Q3	$507M	Sell	3,650,213 -36,174	-1%	-$4.54M	0.16%	127
2018 Q2	$458M	Sell	3,686,387 -81,272	-2%	-$9.5M	0.16%	131
2018 Q1	$420M	Buy	3,767,659 +201,991	+6%	+$24.1M	0.15%	131
2017 Q4	$426M	Buy	3,565,668 +76,689	+2%	+$9.34M	0.15%	136
2017 Q3	$489M	Sell	3,488,979 -259,301	-7%	-$35.2M	0.19%	115
2017 Q2	$456M	Buy	3,748,280 +664,110	+22%	+$77.3M	0.18%	114
2017 Q1	$374M	Buy	3,084,170 +991,274	+47%	+$128M	0.15%	132
2016 Q4	$256M	Buy	2,092,896 +220,447	+12%	+$27M	0.11%	185
2016 Q3	$219M	Buy	1,872,449 +209,897	+13%	+$27M	0.1%	202
2016 Q2	$194M	Buy	1,662,552 +23,378	+1%	+$3.32M	0.09%	214
2016 Q1	$228M	Sell	1,639,174 -67,628	-4%	-$9.93M	0.11%	173
2015 Q4	$326M	Buy	1,706,802 +34,502	+2%	+$6.03M	0.16%	128
2015 Q3	$262M	Buy	1,672,300 +121,340	+8%	+$22.1M	0.14%	140
2015 Q2	$280M	Buy	1,550,960 +245,702	+19%	+$42.4M	0.14%	146
2015 Q1	$226M	Sell	1,305,258 -66,493	-5%	-$12M	0.11%	179
2014 Q4	$254M	Buy	1,371,751 +31,511	+2%	+$5.84M	0.13%	150
2014 Q3	$222M	Sell	1,340,240 -1,320,282	-50%	-$217M	0.12%	167
2014 Q2	$416M	Buy	2,660,522 +1,330,261	+100%	+$210M	0.11%	179
2014 Q1	$202M	Buy	1,330,261 +32,681	+3%	+$5.2M	0.11%	175
2013 Q4	$173M	Sell	1,297,580 -103,075	-7%	-$12.4M	0.1%	203
2013 Q3	$163M	Sell	1,400,655 -80,442	-5%	-$8.83M	0.09%	210
2013 Q2	$137M	Buy	+1,481,097	New	+$143M	0.08%	239

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return